Why this study – using Japanese patient samples – but not other studies could identify the 4G/5G PAI-1 polymorphism as critical for the fibrinolytic response in COVID-19 patients, it is essential to see the differences in the study groups. This evidence concerns the gene SERPINE1 and COVID-19.